Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01916824 · ClinicalTrials.gov registry record · Phase 4
Effects of Treatment on Decision-making in Major Depression
A Phase 4 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 4
- Development phase
- 53
- Enrollment target
NCT01916824 is a Phase 4 study that has completed, run by Emory University. The registered enrollment target is 53 participants.
The verdict
NCT01916824, a Phase 4 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 53 participants
- Enrollment target
Study Summary
In this trial, fifty participants with current major depressive disorder who are not receiving an antidepressant medication and fifty healthy controls will complete questionnaires and computerized tasks to assess their decision-making styles. There will be three visits for depressed patients and two for healthy controls (the first and third visits). The first visit will involve interviews and questionnaires to assess the participant's level of depression, medical history and quality of life. Participants will then complete the decision-making tasks, and will earn between $5-40 based on their choices, in order to make the decisions on the computer tasks financially meaningful. At the completion of this visit, depressed patients will be prescribed an FDA-approved antidepressant, chosen in consultation with the treating psychiatrist. Patients will be responsible for paying for the prescription themselves. After two weeks on the medication, the patient will be seen for a follow-up visit to ensure tolerability of the medicine. After six weeks on the medicine, patients and healthy controls will return to repeat the questionnaires and the computer based decision-making tasks, and will again earn between $5-40 based on their performance.
Interventions
- DRUG Any FDA Approved Antidepressant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2013-08 |
| Est. Completion | 2015-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01916824
The ClinicalTrials.gov registry entry for NCT01916824 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Any FDA Approved Antidepressant is the first listed.
NCT01916824 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01916824 about?
NCT01916824 is a clinical study titled "Effects of Treatment on Decision-making in Major Depression". In this trial, fifty participants with current major depressive disorder who are not receiving an antidepressant medication and fifty healthy controls will complete questionnaires and computerized tasks to assess their decision-making styles. There will be three visits for depressed patients and two...
What is the current status of trial NCT01916824?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 53 participants. The study started on 2013-08. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01916824?
The interventions under investigation include: Any FDA Approved Antidepressant (DRUG).
Who is sponsoring clinical trial NCT01916824?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.